Immunomagnetic techniques for the enrichment and detection of isolated breast carcinoma cells in bone marrow and peripheral blood

Journal of Hematotherapy and Stem Cell Research

Volumn 6, Issue 2, 1997, Pages 103-114

  Naume, Bjørn ^a   Borgen, Elin ^a   Beiske, Klaus ^a   Herstad, Tove Karin ^a   Ravnås, Gry ^a   Renolen, Anne ^a   Trachsel, Sissel ^a   Thrane Steen, Kari ^a   Funderud, Steinar ^a   Kvalheim, Gunnar ^a  

^a OSLO UNIVERSITY HOSPITAL   (Norway)

Author keywords

[No Author keywords available]

Indexed keywords

IMMUNOGLOBULIN G ANTIBODY;

BONE MARROW; BREAST CARCINOMA; CANCER CELL; CELL ISOLATION; CELL SEPARATION; DIAGNOSTIC ACCURACY; DIAGNOSTIC VALUE; HUMAN; HUMAN CELL; IMMUNOCYTOCHEMISTRY; PRIORITY JOURNAL; REVIEW;

BONE MARROW; BREAST NEOPLASMS; CARCINOMA; CELL DIVISION; HUMANS; IMMUNOHISTOCHEMISTRY; IMMUNOMAGNETIC SEPARATION; LEUKOCYTES, MONONUCLEAR; NEOPLASM CIRCULATING CELLS; TUMOR CELLS, CULTURED;

EID: 0031003831     PISSN: 15258165     EISSN: None     Source Type: Journal    
DOI: 10.1089/scd.1.1997.6.103     Document Type: Article

References (32)

1. Mansi, J.L., Berger, U., Easton, D., et al. Micrometastases in bone marrow in patients with primary breast cancer: Evaluation as an early predictor of bone metastases. Br. Med. J. 295:1093, 1987.
2. Harbeck, N., Untch, M., Pache, L., et al. Tumour cell detection in the bone marrow of breast cancer patients at primary therapy: Results of a 3-year median follow-up. Br. J. Cancer 69:566, 1994.
3. Diel, I.J., Kaufmann, M., Goerner, R., et al. Detection of tumor cells in bone marrow of patients with primary breast cancer: A prognostic factor for distant metastasis. J. Clin. Oncol. 10:1534, 1992.
4. Cote, R.J., Rosen, P.P., Lesser, M.L., et al. Prediction of early relapse in patients with operable breast cancer by detection of occult bone marrow micrometastases. J. Clin. Oncol. 9:1749, 1991.
5. Pantel, K., Schlimok, G., Angstwurm, M., et al. Methodological analysis of immunocytochemical screening for disseminated epithelial tumor cells in bone marrow. J. Hematother. 3:165, 1994.
6. Funke, I., Fries, S., Rolle, M., et al. Comparative analyses of bone marrow micrometastases in breast and gastric cancer. Int. J. Cancer 65:755, 1996.
7. Pantel, K., Felber, E. & Schlimok, G. Detection and characterization of residual disease in breast cancer. J. Hematother. 3:315, 1994.
8. Griwatz, C., Brandt, B., Assmann, G., et al. An immunological enrichment method for epithelial cells from peripheral blood. J. Immunol. Methods 183:251, 1995.
9. George, F., Ponchelet, P., Brisson, C., et al. Isolation of endothelial cells from whole blood with S-Endo1 coated magnetic beads. In Magnetic Separation Techniques Applied to Cellular and Molecular Biology, ed. Kemshead, J.T. Cromwell Press Ltd., Wilts, UK, 1991, p. 223.
10. Smeland, E.B., Funderud, S., Kvalheim, G., et al. Isolation and characterization of human hematopoietic progenitor cells: An effective method for positive selection of CD344-cells. Leukemia 6:845, 1992.
11. Kvalheim, G., Sorensen, O., Fodstad, O., et al. Immunomagnetic removal of B-lymphoma cells from human bone marrow: A procedure for clinical use. Bone Marrow Transplant. 3:31, 1988.
12. Kvalheim, G., Fodstad, O., Pihl, A., et al. Elimination of B-lymphoma cells from human bone marrow: Model experiments using monodisperse magnetic particles coated with primary monoclonal antibodies. Cancer Res. 47:846, 1987.
13. Latza, U., Niedobitek, G., Schwarting, R., et al. Ber-EP4: New monoclonal antibody which distinguishes epithelia from mesothelia. J. Clin. Pathol. 43:213, 1990.
14. Leslie, D.S., Johnston, W.W., Daly, L., et al. Detection of breast carcinoma cells in human bone marrow using fluorescence-activated cell sorting and conventional cytology. Am. J. Clin. Pathol. 94:8, 1990.
15. Frankel, A.E., Ring, D.B., Tringale, F., et al. Tissue distribution of breast cancer-associated antigens defined by monoclonal antibodies. J. Biol. Response Mod. 4:273, 1985.
16. de Leij, L., Poppema, S., Elema, J.E., et al. The use of monoclonal antibodies for the pathological diagnosis of lung cancer. In Lung Cancer: Basic and Clinical Aspects, ed. Hansen, H.H. Martinus Nijhoff Publishers, Boston, 1986, p. 31.
17. Fodstad, Ø., Høifødt, H.K., Rye, P.D., et al. New immunobead techniques for sensitive detection of malignant cells in blood and bone marrow. Proc. Am. Assoc. Cancer Res. 37:214 (Abstract), 1996.
18. Kvalheim, G., Fjeld, J.G., Pihl, A., et al. Immunomagnetic removal of B-lymphoma cells using a novel mono-sized magnetizable polymer bead, M-280, in conjunction with primary IgM and IgG antibodies. Bone Marrow Transplant. 4:567, 1989.
19. Kremens, B., Wieland, R., Reuss, R., et al. Enrichment of residual tumor cells in bone marrow or peripheral blood cells in a neuroectodermal tumor model. Pediatr. Hematol. Oncol. 11:625, 1994.
20. Tseng, S.C.G., Jarvinen, M.J., Woodcock-Michell, J., et al. Correlation of specific keratins with different types of epithelial differentiation: Monoclonal antibody studies. Cell 30:361, 1982.
21. Spagnolo, D.V., Michie, S.A., Crabtree, G.S., et al. Monoclonal anti-keratin (AE1) reactivity in routinely processed tissue from 166 human neoplasms. Am. J. Clin. Pathol. 84:697, 1985.
22. Kasper, M., Stosiek, P., Typlt, H., et al. Histological evaluation of three new monoclonal anti-cytokeratin antibodies. 1. Normal tissues. Eur. J Cancer Clin. Oncol. 23:137, 1987.
23. Knapp, W., Dörken, B., Gilks, W.R., et al., eds. Leucocyte Typing IV, White Cell Differentiation Antigens. Oxford University Press, Oxford, 1989.
24. Pantel, K., Schlimok, G., Braun, S., et al. Differential expression of proliferation-associated molecules in individual micrometastatic carcinoma cells. J. Natl. Cancer Inst. 85:1419, 1993.
25. Pantel, K., Schlimok, G., Kutter, D., et al. Frequent downregulation of major histocompatibility class I antigen expression on individual micrometastatic carcinoma cells. Cancer Res. 51:4712, 1991.
26. Schlimok, G., Funke, I., Bock, B., et al. Epithelial tumor cells in bone marrow of patients with colorectal cancer: Immunocytochemical detection, phenotypic characterization, and prognostic significance. J. Clin. Oncol. 8:831, 1990.
27. Datta, Y.H., Adams, P.T., Drobyski, W.R., et al. Sensitive detection of occult breast cancer by the reverse-transcriptase polymerase chain reaction. J. Clin. Oncol. 12:475, 1994.
28. Fields, K.K., Elfenbein, G.J., Trudeau, W.L., et al. Clinical significance of bone marrow metastases as detected using the polymerase chain reaction in patients with breast cancer undergoing high-dose chemotherapy and autologous bone marrow transplantation. J. Clin. Oncol. 14:1868, 1996.
29. Krismann, M., Todt, B., Schröder, J., et al. Low specificity of cytokeratin 19 reverse transcriptase-polymerase chain reaction analyses for detection of hematogenous lung cancer dissemination. J. Clin. Oncol. 13:2769, 1995.
30. Traweek, S.T., Liu, J. & Battifora, H. Keratin gene expression in nonepithelial tissues. Detection with polymerase chain reaction. Am. J. Pathol. 142:1111, 1993.
31. Neumaier, M., Gerhard, M. & Wagener, C. Diagnosis of micrometastases by the amplification of tissue-specific genes. Gene 159:43, 1995.
32. Hardingham, J.E., Kotasek, D., Farmer, B., et al. Immunobead-PCR: A technique for the detection of circulating tumor cells using immunomagnetic beads and the polymerase chain reaction. Cancer Res. 53:3455, 1993.